The real-life experience with cardiovascular complications in the first dose of fingolimod for multiple sclerosis

Overview of attention for article published in Arquivos de Neuro-Psiquiatria, September 2014

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 15 Dimensions

Readers on

mendeley: 27 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 15 publications that cite this research output.

15

The most recent citing publications are shown below. View all 15 publications that cite this research output on Dimensions.

Stroke risk in multiple sclerosis: a critical appraisal of the literature

Article in International Journal of Neuroscience (April 2022)

Risk for Cardiovascular Adverse Events Associated With Sphingosine-1-Phosphate Receptor Modulators in Patients With Multiple Sclerosis: Insights From a Pooled Analysis of 15 Randomised Controlled Trials

Article in Frontiers in Immunology (December 2021)

Cardiac Autonomic Dysfunction in Multiple Sclerosis: A Systematic Review of Current Knowledge and Impact of Immunotherapies

Article in Journal of Clinical Medicine (January 2020)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.